BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SPY072 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SPY072\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07766005-5971@assetmemo.bio
DTSTAMP:20261121T004538Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:SPY072: Phase 2 readout est. (NCT07766005)
DESCRIPTION:SPY072\, phase 2\, Hidradenitis Suppurativa.\nStudy: A Study of
  SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SK
 YLIGHT Trial)\nEstimated primary completion: October 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/spy072#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07766005
URL:https://assetmemo.bio/drug/spy072#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
